SCHEMBL12719002

SCHEMBL12719002

Cc1ccc(-c2cc(C)c(-c3cc(C)c(-c4cc(C)c(F)c(C)c4)c(C)c3)c(C)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.39
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
PTGS2 P35354 4/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGS1 P23219 2/20 0.33
CYP3A4 P08684 1/20 0.33
TSHR P16473 1/20 0.33
AR P10275 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HPRT1 P00492 1/20 0.33
RCE1 Q9Y256 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19186972 0.93 ACHE (0.43) ACHEAKR1C2AKR1C1TDP1PTGS2
SCHEMBL17471814 0.84 RAPGEF4 (0.38) ACHETDP1MEN1ALDH1A1KMT2A
SCHEMBL17070827 0.82 RAPGEF4 (0.35) ACHEPTGS2MEN1KMT2APTGS1
SCHEMBL16521126 0.82 RAPGEF4 (0.35) ACHEPTGS2MEN1KMT2APTGS1
SCHEMBL17471813 0.80 MAPT (0.36) ACHETDP1PTGS2MEN1ALDH1A1
SCHEMBL17471815 0.79 PTGS2 (0.36) AKR1C2PTGS2PTGS1
SCHEMBL17540392 0.78 ALDH1A1 (0.47) ACHETDP1ALDH1A1CYP3A4TSHR
SCHEMBL14173108 0.77 ACHE (0.54) ACHEAKR1C2AKR1C1MEN1KMT2A
SCHEMBL8192072 0.75 ACHE (0.43) ACHETDP1PTGS2MEN1ALDH1A1
SCHEMBL10014228 0.75 ACHE (0.43) ACHETDP1PTGS2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923079-B2 Liquid-crystalline medium and liquid-crystal display comprising 1,2-difluoroethene compounds MERCK PATENT GMBH (DE) 2011-04-12 US disclosed
US-7922934-B2 s-Indacene and indeno[5,6-d][1,3]dioxol-derivatives and use thereof as components of liquid-crystal mixtures MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-04-12 US disclosed
US-20100155662-A1 S-INDACENE AND INDENO[5,6-D][1,3]DIOXOL-DERIVATIVES AND USE THEREOF AS COMPONENTS OF LIQUID-CRYSTAL MIXTURES MERCK PATENT GESELLSCHAFT (DE) 2010-06-24 US disclosed
US-20100085529-A1 LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY COMPRISING 1,2-DIFLUOROETHENE COMPOUNDS WITTEK MICHAEL 2010-04-08 US disclosed
US-7651742-B2 Liquid-crystalline medium and liquid-crystal display comprising 1,2-difluoroethene compounds MERCK PATENT GMBH (DE) 2010-01-26 US disclosed
US-20080260971-A1 Liquid-Crystalline Medium and Liquid-Crystal Display Comprising 1,2-Difluoroethene Compounds MERCK PATENT GMBH (DE) 2008-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100155662-A1 S-INDACENE AND INDENO[5,6-D][1,3]DIOXOL-DERIVATIVES AND USE THEREOF AS COMPONENTS OF LIQUID-CRYSTAL MIXTURES IPO5, SFXN3, SFXN1 ACHE 2650/4885AKR1C2 3007/4885AKR1C1 2976/4885
US-20080260971-A1 Liquid-Crystalline Medium and Liquid-Crystal Display Comprising 1,2-Difluoroethene Compounds CFL1, NEFM, CHRM1 ACHE 2367/4885AKR1C2 3909/4885AKR1C1 3150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.